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Optimizing Sequential Dual Tracer P.E.T.
Studies Using a Combined 2D/3D Imaging
Protocol
John W. Wilson, Timothy G. Turkington, Member, IEEE, James G. Colsher, Member IEEE, Salvador
Borges-Neto, Robert E. Reiman, R. Edward. Coleman

Abstract-- We have investigated a combined 2D/3D protocol
for minimizing contamination in dual tracer P.E.T. studies in
which the tracers are administered on a timescale that is short
compared to the half-lives. We have performed a series of
phantom studies on an Advance and a Discovery ST (GE
Healthcare Technologies), using a torso phantom with cardiac
insert (Data Spectrum Corporation) to simulate a combined FDG
and NH3 scan protocol for a patient with ischemia. The phantom
was imaged in a series of alternating 2D/3D acquisitions as it
decayed over 6 half-lives. By comparing 2D and 3D images, we
have verified that 3D images are of comparable accuracy to 2D
images, even with realistic out-of-field activity challenging the 3D
scans. Based on scan and image statistical quality, we have
recommended optimal doses for maximizing the image quality of
both scans.

D

I.

cardiac perfusion scan (high dose imaged in 2D) [1]. The N13 Ammonia injection and scan follow immediately after the
FDG scan, with the patient remaining on the scan table.
We have performed a series of phantom measurements, with
the goal of optimizing the administered dose of both tracers to
maximize the image quality of both images.

INTRODUCTION

UAL tracer P.E.T. studies suffer from contamination when
the scans are performed on a timescale that is short
compared to the half-lives. To minimize contamination in
the resulting images, we have investigated a technique in
which the first tracer is a low dose imaged in the highersensitivity 3D mode, and the second tracer is a much higher
dose imaged in the lower-sensitivity 2D mode. The specific
protocol we investigate is a combined FDG cardiac viability
scan (initial low dose imaged in 3D) with an N-13 ammonia

Manuscript received November 1, 2004. This work was supported in part
by GE Healthcare Technologies.
J. W. Wilson is with Department of Radiology of Duke University Medical
Center, Durham, NC
27710 USA (telephone: 919-684-7978, e-mail:
jwwilson@petsparc.mc.duke.edu).
T. G. Turkington is with Department of Radiology of Duke University
Medical Center, Durham, NC 27710 USA (telephone: 919-684-7706, e-mail:
timothy.turkington@duke.edu).
J. G. Colsher is with GE Healthcare Technologies, Milwaukee, WI
(telephone: 919-401-8607, e-mail: james.colsher@med.ge.com).
S. Borges-Neto is with Department of Radiology of Duke University
Medical Center, Durham, NC 27710 USA (telephone: 919-684-7857, e-mail:
borge001@mc.duke.edu).
R. E. Reiman is with Duke University Medical Center Durham NC 27710
USA (telephone: 919-668-3186, e-mail: reima001@mc.duke.edu)
R. E. Coleman is with Department of Radiology of Duke University
Medical Center, Durham, NC 27710 USA (telephone: 919-668-3186, e-mail:
colem010@mc. duke.edu).

0-7803-8700-7/04/$20.00 (C) 2004 IEEE

Fig. 1. Phantom setup, showing arms and out-of-field cylindrical phantom.

II. METHODS
We have performed phantom measurements using a torso
phantom with a cardiac insert (Data Spectrum Corp). A 5.4 ml
fillable cardiac defect inside the 110 ml myocardium was used
to simulate both a FDG hot defect (activity in defect, nonradioactive water in myocardium) and NH3 cold defect
(activity in myocardium, non-radioactive water in defect) scans
for a patient with ischemia. For each scan type, realistic
background and liver activity concentrations were used based
on patient data. We use an estimate for the equivalent patient
dose of 5 times the torso-phantom activity. The torso phantom
was aligned in the scanner field of view, with one liter saline
bottles (no activity) simulating arms. A separate 6 liter
cylindrical phantom was placed near the phantom to provide
out-of-field activity.
For each configuration (hot and cold defect) the torso
phantom was imaged in a series of alternating 2D/3D 2 min
acquisitions as it decayed from an initial activity of 560 MBq
of F-18 (with an additional 560 MBq out-of-field activity in
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the cylindrical phantom) for 6.2 half-lives. Data were acquired
on an Advance [2] and a Discovery ST [3] (GE Healthcare
Technologies). All scans were reconstructed using filtered
back projection due to its linearity.
From each image in the decay series, we acquired scan
statistics (i.e., prompt and delayed counts), as well as region
of interest (ROI) values for ~30 myocardium and ~30
background ROI’s.
A. 2D and 3D Accuracy
To justify the combination of 2D and 3D scans in a single
protocol, we first need to verify accuracy of the 3D images. To
do this, we began by forming reduced-noise images by
averaging five two-minute images. From these reduced-noise
images, we extracted myocardial and background ROI’s from
both the 2D and 3D image sets. Taking the low-dose 2D
images as the standard, we performed a region-by region
comparison with the 3D images by dividing each 3D ROI
value from a given slice by the average 2D ROI value from the
same image slice. We expect these normalized ROI values to
have a value near one for good 2D/3D agreement.
Because we are proposing to use a high dose for the 2D
scan, we also need to verify that scanner performance in 2D
does not degrade at high activity levels. To do this, we
compared the average value of 30 2D myocardial ROI’s as a
function of activity, to a linear fit.
B. Evaluating Scan and Image Statistical Quality.
Using the scan statistics (prompt and delayed counts) we
calculated an estimate of statistical quality for both the FDGlike scan and the contaminated NH3 scan as a function of
activity.
In the clinical protocol, the FDG scan is completed before
the NH3 is administered, and therfore it is uncontaminated. We
can therefore model it with the hot defect scan data alone. We
used the true and prompt counts from the hot defect scans to
derive noise equivalent count rate (NEC) [4] curves as a
function of activity.
To calculate statistical quality for an NH3 scan contaminated
with a small amount of residual FDG, we must combine data
from the cold defect scan and the hot defect scan. For the case,
in which the 3D FDG scan has been subtracted from the 2D
NH3 scan, the true counts that contribute to the signal come
only from the cold defect scan, whereas the true and the
prompt counts from both cold and hot defect scans contribute
noise. Knowing this, we can derive an NEC-like estimate of
contaminated scan statistical quality Qcsub as
(Tcold ) 2
,
(1)
Qcsub =
(Pcold + 2 Phot + 2Thot )
where T and P are the true and prompt counts from the hot
and cold defect scans, and the factors of two in the
denominator account for the additional noise added when
subtracting the FDG image from the contaminated NH3 image.
If the FDG image is not subtracted from the contaminated NH3
image, we do not have the additional noise introduced by the
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subtraction. However, the true counts in the FDG scan reduce
the contrast in the contaminated image. For this case we use,

Qc =

(Tcold − Thot ) 2
(Pcold + Phot + Thot ) .

(2)

For all cases we considered, we found that the improvement
in contrast outweighed the increased noise. The rest of this
paper will focus on this case.
To calculate image signal to noise ratio (SNR) for the FDG
scan, we take the signal to be the difference between the
average of the 30 hot myocardial ROI’s and the average value
of the background ROI’s, and the noise to be the standard
deviation of the background ROI’s.
For the contaminated NH3 image, we again must combine
data from the hot and cold defect scans. For the case where the
FDG image is subtracted from the NH3 image, we use
SNR csub =

S cold

σ

2
cold

(3)

2
+ 2σ hot

Where Scold is the difference between the average
myocardial ROI value and the background, and σcold and σhot
are the standard deviations of the cold and hot defect
background ROI’s respectively.
III. RESULTS
A. 2D and 3D Accuracy
Figures 2 and 3 show results for the comparison of 2D and
3D accuracy. In fig. 2, we show a representative reduced-noise
2D and 3D image, and the subtracted image. Profiles through
the images confirm that regional differences are small
compared to image noise.

2D

3D

Difference

Fig. 2. Low-noise 2D and 3D images, and their difference for the Discovery
ST.

Fig. 3 shows the ratio of several 3D myocardial ROI’s and
one 3D background ROI, all from the same randomly chosen
image slice, to the average 2D ROI value from the same slice.
The close agreement with the average 2D value, and the
relatively small deviation in the individual 3D ROI values over
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the chosen image slice validates the use of 3D for low activity
levels.
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Fig. 5. 3D FDG Hot Defect NEC vs. Activity for the Discovery ST.

In Fig. 4, we compare the average 2D myocardial ROI value
as a function of activity to a linear fit. That the 2D ROI values
remain linear with activity up to at least 2500 MBq validates
the use of a large 2D dose.
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Fig. 3. ROI values for four 3D myocardial ROI’s and one background ROI,
normalized to the average 2D ROI value. (Discovery ST)
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Fig. 6. Contaminated NH3 scan statistical Quality vs. Activity for the
Discovery ST.

Figures 7 and 8 show image SNR for the Discovery ST. We
find that, although increasing FDG dose decreases the quality
of the contaminated NH3 scan, there is a point of diminishing
returns, beyond which there is little further gain in SNR, even
with large decreases in FDG dose.
15

15

B. Evaluating Scan Statistical Quality.
Figures 5 and 6 show scan statistical quality for the FDGlike hot defect and the contaminated NH3 cold defect scans for
the Discovery ST. For the NH3 scan, we show curves for
several values of FDG dose. The top-most curve represents the
limit of no FDG contamination, and is equivalent to the 2D
NEC. We see that increasing FDG dose decreases scan
statistical quality, as expected.
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Fig. 4. Average 2D ROI value as a function of activity, compared with a linear
fit.
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Fig. 7. Image Signal to Noise vs. equivalent patient activity for the DST hot
defect scan
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